Prevalence and mechanism of bladder dysfunction in Guillain-Barré syndrome

Neurourology and Urodynamics

Volumn 28, Issue 5, 2009, Pages 432-437

  Sakakibara, Ryuji ^a,b   Uchiyama, Tomoyuki ^b   Kuwabara, Satoshi ^b   Mori, Masahiro ^b   Ito, Takashi ^b   Yamamoto, Tatsuya ^b   Awa, Yusuke ^b   Yamaguchi, Chiharu ^c   Yuki, Nobuhiro ^d   Vernino, Steven ^e   Kishi, Masahiko ^a   Shirai, Kohji ^a  

^a TOHO UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c CHIBA UNIVERSITY HOSPITAL   (Japan)

^d DOKKYO MEDICAL UNIVERSITY   (Japan)

^e UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Acute inflammatory demyelinating polyneuropathy; Acute motor axonal neuropathy; Autonomic dysfunction; Bladder dysfunction; Guillain Barr syndrome

Indexed keywords

GANGLIOSIDE ANTIBODY; IMMUNOGLOBULIN; NICOTINIC RECEPTOR;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ANUS SPHINCTER; ARTICLE; BLADDER DYSFUNCTION; CYSTOMETRY; DEFECATION DISORDER; ELECTROMYOGRAPHY; FEMALE; GUILLAIN BARRE SYNDROME; HOSPITALIZATION; HUMAN; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MOTOR NEUROPATHY; NEUROLOGIC EXAMINATION; OVERACTIVE BLADDER; PATHOGENESIS; PLASMAPHERESIS; POLYRADICULONEUROPATHY; POSTVOID RESIDUAL URINE VOLUME; PREVALENCE; URINARY DYSFUNCTION; URINE RETENTION; URODYNAMICS; UROFLOWMETRY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANAL CANAL; AUTOANTIBODIES; DEFECATION; DIAGNOSTIC TECHNIQUES, UROLOGICAL; ELECTROMYOGRAPHY; FEMALE; GANGLIOSIDES; GUILLAIN-BARRE SYNDROME; HUMANS; LUMBOSACRAL REGION; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RECEPTORS, NICOTINIC; SEVERITY OF ILLNESS INDEX; SPINAL NERVES; URINARY BLADDER; URINATION DISORDERS; URODYNAMICS; YOUNG ADULT;

EID: 67649977537     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.20663     Document Type: Article

References (42)

1. Hughes RA, Swan AV, Raphaël JC, et al. Immunotherapy for Guillain-Barré syndrome: A systematic review. Brain 2007; 130:2245-57.
2. Abrams P, Cardozo L, Fall M, et al. The standardization of terminology of lower urinary tract function: Report from the standardization sub-committee of the international continence society. Neurourol Urodynam 2002;21: 167-78.
3. Kuwabara S. Guillain-Barré syndrome. Curr Neurol Neurosci Rep 2007;7:57-62.
4. Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet 2005;366:1653-66.
5. Hughes RA, Wijdicks EFM, Benson E, et al. Supportive care for patients with Guillain-Barré syndrome. Arch Neurol 2005;62:1194-8.
6. Sakakibara R, Hattori T, Kuwabara S, et al. Micturitional disturbance in patients with Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1997;63:649-53.
7. Guillain-Barré syndrome steroid trial group. Double-blind trial of intravenous methylprednisolone in Guillain-Barré syndrome. Lancet 1993;341: 586-90.
8. Ho TW, Mishu B, Li CY, et al. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118:597-605.
9. Kuwabara S, Nakata M, Sung JY, et al. Hyperreflexia in axonal Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis. J Neurol Sci 2002;199:89-92.
10. Ogawara K, Kuwabara S, Koga M, et al. Anti-GM1b IgG antibody is associated with acute motor axonal neuropathy and Campylobacter jejuni infection. J Neurol Sci 2003;210:41-5.
11. Yuki N. Ganglioside mimicry and peripheral nerve disease. Muscle Nerve 2007;35:691-711.
12. Abrams P, Cardozo L, Fall M, et al. The standardization of terminology of lower urinary tract function; report from the Standardization Subcommittee of the International Continence Society. Neurourol Urodynam 2002;21:167-78.
13. Podnar S, Fowler CJ. Sphincter electromyography in diagnosis of multiple system atrophy: Technical issues. Muscle Nerve 2004;29:151-6.
14. Schäfer W. Principles and clinical application of advanced urodynamic analysis of voiding dysfunction. Urol Clin North Am 1990; 17:553-66.
15. Yamaguchi C, Sakakibara R, Uchiyama T, et al. Overactive bladder in diabetes: A peripheral or central mechanism? Neurourol Urodyn 2007; 26:807-13.
16. Kavia RB, Datta SN, Dasgupta R, et al. Urinary retention in women: Its causes and management. BJU Int 2006;97:281-7.
17. Vernino S. Autoimmune and paraneoplastic channelopathies. Neurotherapeutics 2007;4:305-14.
18. Sawai S, Sakakibara R, Uchiyama T, et al. Acute motor axonal neuropathy presenting with bowel, bladder, and erectile dysfunction. J Neurol 2007; 254:250-2.
19. Sakakibara R, Uchiyama T, Tamura N, et al. Urinary retention and sympathetic sphincter obstruction in axonal Guillain-Barré syndrome. Muscle Nerve 2007;35:111-5.
20. Guillain G, Barré JA, Strohl A. Sur un syndrome de radiculo-névrite avec hyperalbuminose du liquode céphalo-rachidien sans réaction cellulaire; remarques sur les caractéres cliniques et graphiques des réflexes tendineux. Bell Mém Soc Méd Paris 1916;40:1462-70.
21. Guillain G. Radiculoneuritis with acellular hyperalbuminosis of the cerebrospinal fluid. Arch Neurol Psychiat 1936;36:975-90.
22. Truax B. Autonomic disturbance in the Guillain-Barré syndrome. Semin Neurol 1984;4:462-8.
23. Creange A, Temam G, Lefaucheur JP. Lumbosacral acute demyelinating polyneuropathy following hepatitis B vaccination. Autoimmunity 1999;30:143-6.
24. Crino PB, Zimmerman R, Laskowitz D, et al. Magnetic resonance imaging of the cauda equina in Guillain-Barré syndrome. Neurology 1994; 44:1334-6.
25. Goldman AS, Schmalstieg EJ, Freeman DH, Jr., et al. What was the cause of Franklin Delano Roosevelt's paralytic illness? J Med Biogr 2003;11:232-40.
26. Labovitz AE, Mangurten HH. Guillain-Barré syndrome presenting with urinary retention and hypertension. Clin Pediatr (Phila) 2004;43:659-61.
27. Wilmshurst JM, Thomas NH, Robinson RO, et al. Lower limb and back pain in Guillain-Barré syndrome and associated contrast enhancement in MRI of the cauda equina. Acta Paediatr 2001;90:691-4.
28. Lichtenfeld P. Autonomic dysfunction in the Guillain-Barré syndrome. Am J Med 1971;50:772-80.
29. Asahina M, Kuwabara S, Suzuki A, et al. Autonomic function in demyelinating and axonal subtypes of Guillain-Barré syndrome. Acta Neurol Scand 2002;105:44-50.
30. Zochodne DW. Autonomic involvement in Guillain-Barré syndrome; a review. Muscle Nerve 1994;17:1145-55.
31. Gabavac Z, Gilja I, Gubarev N, et al. Neurologic and urodynamic characteristics of patients with Guillain-Barré syndrome. Lijec Vjesn 1989;111:17-20.
32. Honavar M, Tharakan JKJ, Hughes RAC, et al. A clinicopathological study of the Guillain-Barré syndrome; nine cases and literature review. Brain 1991;114:1245-69.
33. Kogan BA, Solomon MH, Diokno AC. Urinary retention secondary to Landry-Guillain-Barré syndrome. J Urol 1981;126:643-4.
34. Wheeler JS, Siroky MB, Pavlakis A, et al. The urological aspects of the Guillain-Barré syndrome. J Urol 1984;131:917-9.
35. Goldstraw MA, Kirby MG, Bhardwa J, et al. Diabetes and the urologist: A growing problem. BJU Int 2006;99:513-7.
36. Muller HD, Beckmann A, Schroder JM. Inflammatory infiltrates in the spinal cord of patients with Guillain-Barré syndrome. Acta Neuropathol (Berl) 2003;106:509-17.
37. Yamanishi T, Yuki T, Yasuda K, et al. The urodynamic evaluation of surgical outcome in patients with urinary retention due to central lumbar disc prolapse. Neurourol Urodynam 2002;21:425.
38. Kalita J, Misra UK, Bansal R. Central motor conduction studies in patients with Guillain Barré syndrome. Electromyogr Clin Neurophysiol 2001;41:243-6.
39. Inoue K, Kohriyama T, Ikeda J, et al. A case of Guillain-Barré syndrome complicated with severe autonomic failure and presented elevated anti-GD1b and anti-GQ1b antibody. Rinsho Shinkeigaku 2002;42:13-7.
40. Kusunoki S. Autonomic involvement in Guillain-Barré syndrome. Rinsho Shinkeigaku 2006;46:878-80.
41. Bhatheja K, Field J. Schwann cells: Origins and role in axonal maintenance and regeneration. Int J Biochem Cell Biol 2006;38:1995-9.
42. Sakakibara R, Uchiyama T, Asahina M, et al. Micturitional disturbance in acute idiopathic autonomic neuropathy. J Neurol Neurosurg Psychiatry 2004;75:287-91.